1-4 of 4
Jeffrey Hellman, PA-C
Close
Sort by
Journal Articles

Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Matthew S. Davids, Haesook T. Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Caron A. Jacobson, MD, Ephraim Hochberg, MD, Ronald Takvorian, MD, Jeremy S. Abramson, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3243.
https://doi.org/10.1182/blood.V128.22.3243.3243
Published: 2016
Journal Articles

TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study

Matthew S. Davids, Haesook T. Kim, PhD, Alyssa Nicotra, BA, Alexandra Savell, BS, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Hari P. Miskin, MS, Peter Sportelli, Asad Bashey, MD PhD, Laura Stampleman, MD, Jens Rueter, MD, Adam Boruchov, MD, Jon Arnason, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Jennifer R. Brown
Journal: Blood
Blood (2016) 128 (22): 641.
https://doi.org/10.1182/blood.V128.22.641.641
Published: 2016
Journal Articles

Preliminary Results of a Phase Ib Study of Duvelisib in Combination with FCR (dFCR) in Previously Untreated, Younger Patients with CLL

Matthew S. Davids, MD, Haesook T. Kim, PhD, Elizabeth Gilbert, Leslie Cowen, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Jon E. Arnason, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4158.
https://doi.org/10.1182/blood.V126.23.4158.4158
Published: 2015
Journal Articles

A Phase II Study of Ofatumumab-High Dose Methylprednisolone Followed By Ofatumumab-Alemtuzumab in 17p Deleted or TP53 Mutated CLL

Matthew S. Davids, MD, Haesook T. Kim, PhD, Stacey M. Fernandes, Jeffrey Hellman, PA-C, Karen Francoeur, RN, Jon E. Arnason, MD, Eric Jacobsen, MD, Ann S LaCasce, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4159.
https://doi.org/10.1182/blood.V126.23.4159.4159
Published: 2015